Search research articles
Contact Us
Filters
Showing results (71-80 of 206) with videos related to
Page
of 21
Sort By:
Chemico-Biological Interactions
|
October 1, 1971
Comparison of the immunosuppressive properties of two related dimethanesulfonates
S Vadlamudi, V S Waravdekar, A Goldin
Cancer Research
|
January 1, 1974
Comparative chemotherapy of AKR lymphoma and human hematological neoplasia
E Frei, F M Schabel, A Goldin
International Journal of Cancer
|
May 15, 1977
Cell kinetics and immunoegenicity of lymphoma cells treated with 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (DIC) in vivo
R Silvestrini, C Testorelli, A Goldin, et al.
Experientia
|
June 15, 1976
Attempt to alter antigenic structure of normal tissues by treatment with dimethyl-triazeno-imidazole-carboxamide in vivo
A Nicolin, R Fagnani, G Nicolotti, et al.
Cancer
|
June 1, 1971
Immunologic response of mice bearing leukemia L1210
E Bonmassar, A Bonmassar, S Vadlamudi, et al.
Cancer Research
|
May 1, 1973
Depression of antilymphoma allograft reactivity by tumor-associated factors
E Bonmassar, A Bonmassar, A Goldin, et al.
Khirurgiia
|
October 1, 1972
[Serotonin and the functional state of the gastrointestinal tract in surgical patients (review of the literature)]
L A Kulikova, V A Goldin, K Appukhami
Cancer Research
|
July 1, 1972
Antigenic changes of L1210 leukemia in mice treated with 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide
E Bonmassar, A Bonmassar, S Vadlamudi, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
April 1, 1970
Reduction of antileukemic and immunosuppressive activities of 5-azacytidine in mice by concurrent treatment with uridine
S Vadlamudi, M Padarathsingh, E Bonmassar, et al.
Cancer Chemotherapy Reports. Part 2
|
November 1, 1972
Some structive-activity relationships for mitomycin C (NSC-26980) derivatives in the treatment of L1210 leukemia
R Kojima, J Driscoll, N Mantel, et al.
Page
of 21
Search research articles
Search
Showing results (71-80 of 206) with videos related to
Sort By:
Page
of 21
Chemico-Biological Interactions
|
October 1, 1971
Comparison of the immunosuppressive properties of two related dimethanesulfonates
S Vadlamudi, V S Waravdekar, A Goldin
Cancer Research
|
January 1, 1974
Comparative chemotherapy of AKR lymphoma and human hematological neoplasia
E Frei, F M Schabel, A Goldin
International Journal of Cancer
|
May 15, 1977
Cell kinetics and immunoegenicity of lymphoma cells treated with 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (DIC) in vivo
R Silvestrini, C Testorelli, A Goldin, et al.
Experientia
|
June 15, 1976
Attempt to alter antigenic structure of normal tissues by treatment with dimethyl-triazeno-imidazole-carboxamide in vivo
A Nicolin, R Fagnani, G Nicolotti, et al.
Cancer
|
June 1, 1971
Immunologic response of mice bearing leukemia L1210
E Bonmassar, A Bonmassar, S Vadlamudi, et al.
Cancer Research
|
May 1, 1973
Depression of antilymphoma allograft reactivity by tumor-associated factors
E Bonmassar, A Bonmassar, A Goldin, et al.
Khirurgiia
|
October 1, 1972
[Serotonin and the functional state of the gastrointestinal tract in surgical patients (review of the literature)]
L A Kulikova, V A Goldin, K Appukhami
Cancer Research
|
July 1, 1972
Antigenic changes of L1210 leukemia in mice treated with 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide
E Bonmassar, A Bonmassar, S Vadlamudi, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
April 1, 1970
Reduction of antileukemic and immunosuppressive activities of 5-azacytidine in mice by concurrent treatment with uridine
S Vadlamudi, M Padarathsingh, E Bonmassar, et al.
Cancer Chemotherapy Reports. Part 2
|
November 1, 1972
Some structive-activity relationships for mitomycin C (NSC-26980) derivatives in the treatment of L1210 leukemia
R Kojima, J Driscoll, N Mantel, et al.
Page
of 21